Definium Therapeutics (DFTX) Enterprise Value (2020 - 2026)
Definium Therapeutics (DFTX) reported Enterprise Value of -$368.1 million for Q1 2026, down 75.3% year-over-year from -$1.5 billion in Q1 2025, and up 10.01% quarter-over-quarter from -$409.1 million in Q4 2025.
Definium Therapeutics (DFTX) Enterprise Value (2020 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of Enterprise Value data on file, last reported at -$368.1 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$368.1 million, down 75.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$368.1 million (down 75.3% YoY), and the FY2025 annual result was -$409.1 million, down 50.67% from the prior year.
- Enterprise Value improved to -$368.1 million in Q1 2026 per DFTX's latest filing, from -$409.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$99.7 million in Q4 2023 and troughed at -$409.1 million in Q4 2025.
- A 5-year average of -$204.8 million and a median of -$196.0 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 172.31% in 2024, then grew 29.2% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$131.7 million in 2022, then gained by 24.29% to -$99.7 million in 2023, then plunged by 172.31% to -$271.5 million in 2024, then plunged by 50.67% to -$409.1 million in 2025, then climbed by 10.01% to -$368.1 million in 2026.
- Business Quant data shows DFTX's Enterprise Value at -$368.1 million in Q1 2026, -$409.1 million in Q4 2025, and -$209.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | -368.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -368.10 Mn |
| Dec 31, 2025 | -409.06 Mn |
| Sep 30, 2025 | -209.06 Mn |
| Jun 30, 2025 | -182.99 Mn |
| Mar 31, 2025 | -209.99 Mn |
| Dec 31, 2024 | -271.50 Mn |
| Sep 30, 2024 | -295.28 Mn |
| Jun 30, 2024 | -242.40 Mn |
| Mar 31, 2024 | -249.10 Mn |
| Dec 31, 2023 | -99.70 Mn |
| Sep 30, 2023 | -115.30 Mn |
| Jun 30, 2023 | -116.90 Mn |
| Mar 31, 2023 | -129.41 Mn |
| Dec 31, 2022 | -131.70 Mn |
| Sep 30, 2022 | -140.60 Mn |
| Jun 30, 2022 | -105.74 Mn |
| Dec 31, 2020 | -80.09 Mn |